CompletedNot Applicable

FETAL PULMONARY VEIN AND UMBILICAL ARTERY PULSATILITY INDICES AS PREDICTORS OF FETAL GROWTH RESTRICTION IN DIABETIC AND HYPERTENSIVE PREGNANT WOMEN

Egypt82 participantsStarted 2024-07-01

Plain-language summary

Diabetic and hypertensive pregnant women attending at Kasr Alani for antenatal care were subjected to Complete History taking. All the participants were scanned using B mode sonography to determine the fetal biometric parameters (BPD, HC, AC and FL).Only umbilical artery pulsatility index (UAPI) and pulmonary vein pulsatility index (PVPI) were measured in the study. UAPI and PVPI were measured between 28 and 34 weeks of gestation at the first routine ultrasound scheduled.

Who can participate

Age range18 Years – 44 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women between 18 and 44 years. * Gestational age: 28 - 34 weeks of gestation at time of examination (only women with confirmed GA by sure LMP and/or first trimester US scan). * Singleton pregnancy. * Hypertensive women (preexisting or gestational hypertension). * Diabetic women (preexisting or gestational diabetes). Exclusion Criteria: * Women with any medical disorder (apart from diabetes and hypertension). * Women with multiple pregnancies. * Women with inadequate ultrasound images (i.e., marked obesity). * Women with fetuses with chromosomal abnormalities or congenital anomalies and other factors that could affect fetal growth. * Unavailable perinatal outcome data

What they're measuring

Prediction of fetal growth restriction

Timeframe: At time of delivery

Trial details

NCT IDNCT06988436

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-15

View on ClinicalTrials.gov More Intrauterine Growth Restriction trials